Parkman Elastomers Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 23 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.50 M
- Revenue Growth 6.10%
- Profit Growth -55.69%
- Ebitda -53.02%
- Net Worth 6.73%
- Total Assets 10.26%
About Parkman Elastomers
Parkman Elastomers Private Limited (PEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 April 2001 and has a history of 23 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹7.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hemal Manek and Sushma Manek serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U25191MH2001PTC131483
-
Company No.
131483
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Apr 2001
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Parkman Elastomers?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemal Manek
|
Director | 03-Apr-2001 | Current |
|
Sushma Manek
|
Director | 03-Apr-2001 | Current |
Financial Performance of Parkman Elastomers.
Parkman Elastomers Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.1% increase. The company also saw a substantial fall in profitability, with a 55.69% decrease in profit. The company's net worth moved up by a moderate rise of 6.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parkman Elastomers?
In 2023, Parkman Elastomers had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹7.50 M
Charges Breakdown by Lending Institutions
- The Saraswat Co-Op Bank Ltd : 0.50 Cr
- The Saraswat Co Operative Bank Ltd : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jun 2013 | The Saraswat Co-Op Bank Ltd | ₹5.00 M | Satisfied |
| 21 Jul 2004 | The Saraswat Co Operative Bank Ltd | ₹0.50 M | Satisfied |
| 01 Oct 2001 | The Saraswat Co Operative Bank Ltd | ₹2.00 M | Satisfied |
How Many Employees Work at Parkman Elastomers?
Parkman Elastomers has a workforce of 18 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parkman Elastomers, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parkman Elastomers's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
